TRIM24 binds chromatin and the estrogen receptor to activate estrogen-dependent genes linked to cellular proliferation and tumor development, with its PHD-bromodomain providing a structural rationale for chromatin activation through a noncanonical histone signature [16]. The gene discussed is TRIM24; the disease is neoplasm.